1. Home
  2. MBIO vs BYAH Comparison

MBIO vs BYAH Comparison

Compare MBIO & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.62

Market Cap

5.6M

Sector

Health Care

ML Signal

N/A

Logo Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co. Ltd. Ordinary Shares

HOLD

Current Price

$0.39

Market Cap

5.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
BYAH
Founded
2015
2016
Country
United States
China
Employees
N/A
40
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.0M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
BYAH
Price
$0.62
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.0K
2.9M
Earning Date
05-13-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.05
52 Week High
$2.19
$6.49

Technical Indicators

Market Signals
Indicator
MBIO
BYAH
Relative Strength Index (RSI) 42.39 32.44
Support Level $0.64 $0.14
Resistance Level $0.82 $1.34
Average True Range (ATR) 0.05 0.15
MACD -0.01 -0.05
Stochastic Oscillator 26.01 2.36

Price Performance

Historical Comparison
MBIO
BYAH

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

Share on Social Networks: